Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes

Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes

Faraz Razi,1 Adnaan Haq,2 Prabhu Tonne,3 Maharatnam Logendran3 1Department of Paediatrics, Basingstoke and North Hampshire Hospital, Basingstoke, UK; 2Department of Ophthalmology, Leicester General Hospital, Leicester, UK; 3Department of Ophthalmology, Northampton General Hospital, Northampton, UK...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Razi F, Haq A, Tonne P, Logendran M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Long-term results – Lucentis – Neovascular AMD
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/68d1772552b340c8941b672531224913
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares